Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
PlexusDx partners with licensed 503A compounders to deliver personalized semaglutide therapy at $189/mo month-to-month, or from $149/mo on the 6-month plan, with no insurance requirement and full HSA/FSA eligibility
Optimizing dosing schedules and administration routes is critical to maximize therapeutic efficacy while minimizing adverse effects such as hypoglycemia and gastrointestinal intolerance
Semaglutide is not indicated for the treatment of type 1 diabetes
In this study, 120 patients were split into 3 groups
In the completed STEP trials, semaglutide 2.4 mg as an adjunct to lifestyle intervention led to mean body weight losses of ~1517% over 68 weeks in patients without T2D (STEP 1, 3 and 4), with a smaller mean weight loss of 9.6% seen in patients with T2D over the same period (STEP 2)
Published 2019 Apr 1
US$ 20.53
US$ 25.99
US$ 25.81
